Loading insider details...
Beta
Latest Form 4 (Feb 27, 2026): Grant/Award of 25,000 INDP shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 27, 2026 | Indaptus Therapeutics, Inc. (INDP) | Grant/Award | 25,000 | n/a |
| May 2, 2025 | Matinas BioPharma Holdings, Inc. (MTNB) | Grant/Award | 70,100 | n/a |
| Dec 15, 2023 | Matinas BioPharma Holdings, Inc. | Grant/Award | 3,500,000 | n/a |
| Dec 22, 2022 | Matinas BioPharma Holdings, Inc. (MTNB) | Grant/Award | 1,988,300 | n/a |
| Dec 15, 2021 | Matinas BioPharma Holdings, Inc. (MTNB) | Grant/Award | 1,658,100 | n/a |
| Jun 24, 2021 | Matinas BioPharma Holdings, Inc. (MTNB) | Other (see footnotes) | 6,000 | n/a |
| Jan 4, 2021 | Matinas BioPharma Holdings, Inc. (MTNB) | Grant/Award | 1,600,000 | n/a |
| Jun 24, 2020 | Matinas BioPharma Holdings, Inc. (MTNB) | Other (see footnotes) | 4,500 | n/a |
| Jun 19, 2020 | Matinas BioPharma Holdings, Inc. (MTNB) | Grant/Award | 500,000 | n/a |
| Mar 18, 2020 | Matinas BioPharma Holdings, Inc. (MTNB) | Purchase | 10,000 | $6.5K |